AGC Biologics A/S

CVR 25950941 · Public limited company (A/S) · Active · Low risk

AGC Biologics A/S is a Public limited company (A/S), founded on , based in Søborg. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 312.0m and a net result of DKK -328.0m.

Bankruptcy risk for AGC Biologics A/S

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 27% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×
Equity ratio0%–10% · bankruptcy rate 10.2%1.2×

Reduces the risk

Reporting classReporting class C, large enterprise · bankruptcy rate 0.2%0.03×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Employees (latest year)100+ · bankruptcy rate 2.3%0.27×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
25950941
Status
Active
Company type
Public limited company (A/S)
Founded
(25 years)
Address
Vandtårnsvej 83
2860 Søborg
Municipality
Gladsaxe
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 42.9m
Employees
346 (2018)
Auditor
KPMG P/S
Audit opted out
No

Warning signs

Annual reports filed late4 of 25
Missing annual reportNo
Negative equityNo
Equity ratio7.7%
Current ratio56%
Moves (last 2 years)0
CEO changes in total22
CEO's previous bankruptcies0
Other companies at the address24
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
RevenueDKK 2.0bnDKK 2.0bnDKK 2.1bn
Gross profitDKK -91.2mDKK 160.2mDKK 500.7m
Net profitDKK -328.0mDKK -115.0mDKK 243.9m
EquityDKK 312.0mDKK 640.0mDKK 307.4m
Total assetsDKK 4.1bnDKK 3.8bnDKK 3.6bn
CashDKK 100.7mDKK 74.4m–
Short-term debtDKK 2.2bnDKK 1.5bn–
Tax owed–DKK 0–
Avg. employees1,1381,019–

Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · KPMGStatsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025180
1 Jan 2024 – 31 Dec 2024192 Late
1 Jan 2023 – 31 Dec 2023186 Late
1 Jan 2022 – 31 Dec 2022180
1 Jan 2021 – 31 Dec 2021178
1 Jan 2020 – 31 Dec 2020165
1 Jan 2019 – 31 Dec 2019150
1 Jan 2018 – 31 Dec 2018151
1 Jan 2017 – 31 Dec 2017157
1 Jan 2016 – 31 Dec 2016160
1 Jan 2015 – 31 Dec 2015160
1 Jan 2014 – 31 Dec 2014170
1 Jan 2013 – 31 Dec 2013155
1 Jan 2012 – 31 Dec 2012153
1 Jan 2011 – 31 Dec 2011152
1 Jan 2010 – 31 Dec 2010213 Late
1 Jan 2009 – 31 Dec 2009178
1 Jan 2008 – 31 Dec 2008154
1 Jan 2007 – 31 Dec 2007157
1 Jan 2006 – 31 Dec 200693

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOLone Fønss Schrøder
CEOAnders Vinther
CEOChristian Henrik Tange
CEOStephen John Bellis
CEOMads Aage Laustsen
CEOJens Malta Velling
CEODouglas Robert Sanders
CEOClaès Johan Robert Glassell
CEOGustavo Fabio Mahler
CEOPatricio Ezequiel Massera
CEOKasper Møller
BoardKasper MøllerCurrent
BoardTadashi MuranoCurrent
BoardAlberto SantagostinoCurrent
BoardMai IwayaCurrent
BoardYuichiro TashiroCurrent
BoardLars Hallgren
BoardMads Aage Laustsen
BoardMorten Boje Munk
BoardFrank Harder
BoardMette Kirstine Agger
BoardMorten Boje Munk
BoardBjörn Carl-Johan Dellgren
BoardJuha Aimo Koivurinta
BoardDavid Kauffmann
BoardPaul Howard Michael Toon
BoardClaès Johan Robert Glassell
BoardThomas Léon Yves Marie Balland
BoardThomas Tscherning
BoardJesper Zeuthen
BoardWilliam John Henry
BoardThomas Léon Yves Marie Balland
BoardMads Aage Laustsen
BoardStephen Andrew Lehman
BoardClaes Johan Robert Glassell
BoardClaès Johan Robert Glassell
BoardMads Aage Laustsen
BoardPatricio Ezequiel Massera
BoardJesper Bramming
BoardPeter Klarskov Vilby
BoardHideyuki Kurata
BoardIkuo Matsukura
BoardMasahiko Fukamachi
BoardYukiteru Nakashita
BoardHiroshi Nishimura
BoardNoriyuki Komuro
BoardHideyuki Kurata
BoardNoriyuki Komuro
BoardHideaki Kan
BoardPatricio Ezequiel Massera
BoardTomoko Miyagawa
BoardAkira Nakamura
Owner (100%)Asahi Glass Co., Ltd.Current
Owner (90%)CMC Biologics III S.C.S.
Owner (100%)CMC Biologics III S.C.S.
Owner (5%)CMC Biologics S.à r.l.
AuditorKPMG P/SCurrent
AuditorGert Fisker Tomczyk
AuditorGreen IV ApS
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderCATCH THE WAVES ApSCurrent
FounderEAGLE ApSCurrent
FounderMR BIOINVEST ApSCurrent
FounderGINNIGUP HOLDING ApSCurrent
FounderATLINE HOLDING ApSCurrent
FounderPROVISION ApSCurrent

The CEOs' other companies

Lone Fønss Schrøder – 17 other companies, of which 4 bankrupt

Anders Vinther – 1 other companies

Christian Henrik Tange – 5 other companies

Mads Aage Laustsen – 5 other companies

Jens Malta Velling – 3 other companies

Kasper Møller – 2 other companies

Address history (2 moves)

Vandtårnsvej 83, 2860 Søborg
Fruebjergvej 3, 2100 København Ø
c/o direktør Mads Laustsen, Nybrovej 136, 2800 Kgs.Lyngby

Former names

AGC Biologics A/S – now
CMC BIOLOGICS A/S –
CMC BIOPHARMACEUTICALS A/S –
CMC BIOTECH A/S –

Employees per year

Number of employees at AGC Biologics A/S per year1733462011: 17820112012: 17820122013: 21120132014: 22320142015: 23620152016: 29420162017: 32620172018: 3462018

Other companies at the same address

Similar companies in Gladsaxe

Questions and answers about AGC Biologics A/S

Has AGC Biologics A/S gone bankrupt?

No, AGC Biologics A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of AGC Biologics A/S?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of AGC Biologics A/S?

AGC Biologics A/S most recently used KPMG P/S.

When was AGC Biologics A/S founded?

AGC Biologics A/S was founded on 15 March 2001.

What is the equity of AGC Biologics A/S?

Equity was DKK 312.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.